Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeselskabet Hårby I/S Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   4.9% 2.3% 6.8% 5.1% 8.6% 13.7% 14.3% 14.3%   Credit score (0-100)   46 66 35 42 28 15 15 15   Credit rating   BBB BBB BBB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,977 6,241 10,289 10,093 10,603 10,646 0.0 0.0   EBITDA   597 1,506 5,109 5,413 6,836 7,429 0.0 0.0   EBIT   597 1,506 5,109 5,413 6,836 7,429 0.0 0.0   Pre-tax profit (PTP)   565.9 1,566.7 5,195.3 5,512.7 6,969.2 7,487.7 0.0 0.0   Net earnings   565.9 1,566.7 5,195.3 5,512.7 6,969.2 7,487.7 0.0 0.0   Pre-tax profit without non-rec. items   566 1,567 5,195 5,513 6,969 7,488 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   0.0 0.0 0.0 0.0 6,969 7,488 0.0 0.0   Interest-bearing liabilities   2,375 1,486 1,873 3,975 1,861 1,448 0.0 0.0   Balance sheet total (assets)   3,553 2,836 2,981 4,462 2,259 1,886 0.0 0.0   Net Debt   2,369 1,165 -35.9 3,601 1,112 1,419 0.0 0.0     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,977 6,241 10,289 10,093 10,603 10,646 0.0 0.0   Gross profit growth   19.8% 4.4% 64.9% -1.9% 5.1% 0.4% -100.0% 0.0%   Employees   8 8 8 7 7 5 0 0   Employee growth %   0.0% 0.0% 0.0% -12.5% 0.0% -28.6% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,553 2,836 2,981 4,462 2,259 1,886 0 0   Balance sheet change%   -9.9% -20.2% 5.1% 49.7% -49.4% -16.5% -100.0% 0.0%   Added value   597.4 1,506.1 5,108.9 5,413.5 6,836.0 7,428.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   10.0% 24.1% 49.7% 53.6% 64.5% 69.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   16.2% 49.2% 178.9% 148.3% 207.6% 362.8% 0.0% 0.0%   ROI %   21.0% 77.1% 291.3% 188.8% 239.1% 454.4% 0.0% 0.0%   ROE %   15.1% 49.0% 178.6% 148.1% 121.9% 103.6% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   0.0% 0.0% 0.0% 0.0% 75.5% 79.9% 0.0% 0.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   396.5% 77.4% -0.7% 66.5% 16.3% 19.1% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 26.7% 19.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.4% 0.2% 0.5% 0.2% 0.3% 1.9% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   1.0 1.1 0.9 1.0 0.9 0.9 0.0 0.0   Current Ratio   1.0 1.1 1.0 1.0 1.0 1.0 0.0 0.0   Cash and cash equivalent   6.3 320.6 1,908.6 374.6 749.4 29.9 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   0.0 213.1 0.0 -0.0 0.0 0.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   75 188 639 773 977 1,486 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   75 188 639 773 977 1,486 0 0   EBIT / employee   75 188 639 773 977 1,486 0 0   Net earnings / employee   71 196 649 788 996 1,498 0 0